Enhancing the Anticancer Effect of Androgen Deprivation Therapy by Monocarboxylate Transporter 1 Inhibitor in Prostate Cancer Cells

PCa cells (LNCaP and C4-2 cell line), which has high prostate-specific membrane antigen (PSMA) and androgen receptor (AR) expression among PCa cell lines, were used in this study.